Auspex Pharmaceuticals Lands $1,500,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c2b8624c-02f9-4865-8aa9-5326c1f9269a&Preview=1 - Date
8/1/2012 - Company Name
Auspex Pharmaceuticals - Mailing Address
3366 North Torrey Pines Court La Jolla, CA 92037 - Company Description
Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs. For more than five years the company has worked to apply its targeted deuteration strategy to drug molecules across multiple therapeutic areas, secure a proprietary position on several hundred compounds and initiate development on multiple clinical candidates. - Website
http://www.auspexpharma.com - Transaction Type
Debt - Transaction Amount
$1,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
